Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 4 2Phase 3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Withdrawn 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 2Breast 2Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Endometrial Neoplasms 1Appendiceal Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Lansoprazole × Clear all
NCT04188119 2025-12-08

IMpALA

The Christie NHS Foundation Trust

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

NCT03192059 2021-09-08

PRIMMO

University Hospital, Ghent

Phase 2 Completed
43 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT03794596 2019-07-22

IMpALA

The Christie NHS Foundation Trust

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed
71 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT02388581 2016-03-25

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

National Health Research Institutes, Taiwan

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡